Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Integer Holdings (ITGR) Research & Development (2016 - 2025)

Historic Research & Development for Integer Holdings (ITGR) over the last 16 years, with Q3 2025 value amounting to $10.9 million.

  • Integer Holdings' Research & Development fell 816.91% to $10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.0 million, marking a year-over-year decrease of 1048.5%. This contributed to the annual value of $53.4 million for FY2024, which is 1378.48% down from last year.
  • Integer Holdings' Research & Development amounted to $10.9 million in Q3 2025, which was down 816.91% from $14.2 million recorded in Q2 2025.
  • In the past 5 years, Integer Holdings' Research & Development registered a high of $19.1 million during Q1 2023, and its lowest value of $10.6 million during Q4 2024.
  • Over the past 5 years, Integer Holdings' median Research & Development value was $14.1 million (recorded in 2023), while the average stood at $14.1 million.
  • Its Research & Development has fluctuated over the past 5 years, first soared by 3380.08% in 2022, then crashed by 1999.79% in 2024.
  • Quarter analysis of 5 years shows Integer Holdings' Research & Development stood at $12.7 million in 2021, then dropped by 0.4% to $12.7 million in 2022, then grew by 2.88% to $13.0 million in 2023, then dropped by 18.67% to $10.6 million in 2024, then grew by 3.16% to $10.9 million in 2025.
  • Its Research & Development was $10.9 million in Q3 2025, compared to $14.2 million in Q2 2025 and $14.2 million in Q1 2025.